التفاصيل البيبلوغرافية
| العنوان: |
ARID1A loss activates MAPK signaling via DUSP4 downregulation. |
| المؤلفون: |
Mandal, Jayaprakash1,2,3 (AUTHOR), Yu, Zheng-Cheng1,2,3 (AUTHOR), Shih, Ie-Ming1,2,3 (AUTHOR) ishih@jhmi.edu, Wang, Tian-Li1,2,3 (AUTHOR) tlw@jhmi.edu |
| المصدر: |
Journal of Biomedical Science. 12/9/2023, Vol. 30 Issue 1, p1-14. 14p. |
| مصطلحات موضوعية: |
*MITOGEN-activated protein kinases, *MITOGEN-activated protein kinase phosphatases, *TUMOR suppressor genes, *DOWNREGULATION, *HISTONE acetylation |
| مستخلص: |
Background: ARID1A, a tumor suppressor gene encoding BAF250, a protein participating in chromatin remodeling, is frequently mutated in endometrium-related malignancies, including ovarian or uterine clear cell carcinoma (CCC) and endometrioid carcinoma (EMCA). However, how ARID1A mutations alter downstream signaling to promote tumor development is yet to be established. Methods: We used RNA-sequencing (RNA-seq) to explore transcriptomic changes in isogenic human endometrial epithelial cells after deleting ARID1A. Chromatin immunoprecipitation sequencing (ChIP-seq) was employed to assess the active or repressive histone marks on DUSP4 promoter and regulatory regions. We validated our findings using genetically engineered murine endometroid carcinoma models, human endometroid carcinoma tissues, and in silico approaches. Results: RNA-seq revealed the downregulation of the MAPK phosphatase dual-specificity phosphatase 4 (DUSP4) in ARID1A-deficient cells. ChIP-seq demonstrated decreased histone acetylation marks (H3K27Ac, H3K9Ac) on DUSP4 regulatory regions as one of the causes for DUSP4 downregulation in ARID1A-deficient cells. Ectopic DUSP4 expression decreased cell proliferation, and pharmacologically inhibiting the MAPK pathway significantly mitigated tumor formation in vivo. Conclusions: Our findings suggest that ARID1A protein transcriptionally modulates DUSP4 expression by remodeling chromatin, subsequently inactivating the MAPK pathway, leading to tumor suppression. The ARID1A-DUSP4-MAPK axis may be further considered for developing targeted therapies against ARID1A-mutated cancers. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder